The rationale for sentinel-node biopsy in primary melanoma
- PMID: 18679393
- PMCID: PMC2574663
- DOI: 10.1038/ncponc1205
The rationale for sentinel-node biopsy in primary melanoma
Comment on
-
Why perform sentinel-lymph-node biopsy in patients with melanoma?Nat Clin Pract Oncol. 2008 Jan;5(1):1. doi: 10.1038/ncponc1022. Nat Clin Pract Oncol. 2008. PMID: 18097452 No abstract available.
-
Prognostic false-positivity of the sentinel node in melanoma.Nat Clin Pract Oncol. 2008 Jan;5(1):18-23. doi: 10.1038/ncponc1014. Nat Clin Pract Oncol. 2008. PMID: 18097453 Review.
References
-
- Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol. 2008;5:18–23. - PubMed
-
- Rosenberg SA. Why perform sentinel-lymph-node biopsy in patients with melanoma? Nat Clin Pract Oncol. 2008;5:1. - PubMed
-
- Morton DL, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307–1317. - PubMed
-
- Morton DL the MSLT-II Trials Group. Interim update of MSLT-I and MSLT-II. Sixth Biennial International Sentinel Node Society Meeting; Sydney, Australia. February 18–20, 2008.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical